tbuckley/cabot-search huggingface dataset:
Awaited
Authors: Stanley Cohen
Journal: Annals of Internal Medicine (2015)

Ad Libitum1 December 2015AwaitedStanley Cohen, MDStanley Cohen, MDFrom Atlanta, Georgia.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M15-2032 Audio Reading - “Awaited” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Awaited," by S. Cohen. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The fragile left hand wavedFrom the amniotic murka thousand evolutions awayand then imagined a million pixelsonto my computer screenrising up, reaching for reality,an existence as more than afish growing into frog intomy soon-to-be grandson.There is no demand as yetno ultimatum for life outside,rather the safety to synthesizelungs and heart, to assure us laterthat God too countedthe right number of toes. Author, Article, and Disclosure InformationAffiliations: From Atlanta, Georgia.Current Author Address: Stanley Cohen, MD, Children's Center for Digestive Health Care, 993D Johnson Ferry Road, #440, Atlanta, GA 30342; e-mail, [email protected]com. PreviousarticleNextarticle Advertisement Audio Reading - “Awaited” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Awaited," by S. Cohen. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetails Metrics 1 December 2015Volume 163, Issue 11Page: 847KeywordsChild healthChildrenComputersHealth careHeartLungsSafety ePublished: 1 December 2015 Issue Published: 1 December 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Primer on allergic and immunologic diseases
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Recurrent pericarditis and celiac disease
Authors: L. A. Laine
Journal: JAMA (1984)

IDIOPATHIC pericarditis is among the most common forms of recurrent pericarditis.<sup>1</sup>After a thorough evaluation to exclude other, treatable causes, idiopathic pericarditis is usually treated symptomatically with rest and anti-inflammatory medications.<sup>1</sup>Two recent reports from Great Britain<sup>2,3</sup>have described a potentially curable cause of "idiopathic" recurrent pericarditis: celiac disease. To the best of our knowledge, the association between recurrent pericarditis and celiac disease has not been reported previously in this country. <h3>Report of a Case</h3> A 63-year-old man was first admitted to the San Diego Veterans Administration Medical Center in 1976 with left-sided pleuritic chest pain. The patient had a pericardial rub, and chest roentgenograms showed a transient left pleural effusion. A diagnosis of pleuropericarditis was made. He was treated with aspirin, and his pain resolved. In 1981, the patient again had pleuritic chest pain. A three-component pericardial rub was heard. An ECG showed diffuse ST elevation,
Breast-conservation operations for treatment of cancer of the breast
Authors: A. E. Baue
Journal: JAMA (1994)

In this issue ofThe Journal, Lee-Feldstein et al<sup>1</sup>report on the operative treatment and survival of patients with breast cancer categorized by the type and size of hospitals in which the therapy was performed. The authors conclude that a larger percentage of breast-conserving operations for small localized (negative axillary lymph nodes) or regional (positive axillary lymph nodes) cancers of the breast were done in teaching hospitals and a much lower percentage in small hospitals. The results of breast conservation were as good as the more radical operations. Local excision, lymph node dissection, and radiation therapy provided the best long-term results. Also, survival of patients with localized disease was significantly better at large community hospitals, compared with small hospitals, and was worse at health maintenance organization hospitals. Based on their observations and the recommendations of the National Institutes of Health (NIH) conference in 1990 on the treatment of early-stage
THE SO-CALLED "PECULIAR PEOPLE" AND CONTAGIOUS DISEASE.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Author Index
Authors: Kenton L. Burns, M. von Rad, H.E. Pelser, J.J. Groen, Stuyling de Lange, P.C. Dix, Thomas L. Creer, Kenton L. Burns, M. Kütemeyer, H. Becker, G.N. Christodoulou, A. Gargoulas, A. Papaloukas, A. Marinopoulou, A.D. Rabavilas, Nils H. Houge, M. Mitscherlich, T. Onat, G. Koptagel-Ilal, G. Enbiyaoğlu, M. Mahmutoğlu, N. Uçtum, F. Askevold, F. Askevold, Finn Askevold, Renata Gaddini, R.A. Pierloot, Walter Bräutigam, Kåre Rodahl, Zdenek Vokac, Per Fugelli, Ivar Hartviksen, Sanford I. Cohen, R. Kellner, S. Stephanos, P.-B. Schneider, F. Wulliemier, M. Wirsching, H. Stierlin, Chase Patterson Kimball, H.-J. Meffert, B. Dahme, B. Flemming, P. Götze, G. Huse-Kleinstoll, G. Rodewald, H. Speidel, Hellmuth Freyberger, Marianne Ludwig, Marlene Mangels, Peter Neuhaus, Adam J. Krakowski, J. Vinck, Roberta J. Apfel, Peter E. Sifneos, Tetsuya Nakagawa, Mineyasu Sugita, Yoshihide Nakai, Yujiro Ikemi, J.W. Paulley, D.A. Sturgeon, W. Knauss, P.E. Sifneos, Finn Askevold, Arvid Heiberg, Haruyoshi Yamamoto, Jinichi Suzuki, Yuichi Yamauchi, George Spyros Philippopoulos, Tom Andersen, Hellmuth Freyberger
Journal: Psychotherapy and Psychosomatics (1979)
Elder Abuse and Neglect Concern AMA-RPS
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
"MEDICAL EDUCATION"
Authors: Daniel S. Hager
Journal: JAMA (1924)

<h3>To the Editor:</h3> —The editorial on medical education together with Pusey's published letter is so timely and to the point that, in my opinion, they deserve more than passing notice. While I personally believe that medicine is in a condition of "flux" that may ultimately mean what Rev. E. A. Hersh said at the Rush commencement about sixteen years ago, when he stated that some day the doctor would again become the priest of the people and the present priests would step out, this evolution is no doubt a long way off. Meanwhile, "it is a condition and not a theory that confronts us." I believe that much could be done to change this condition for the better ideals for which the profession stands. These things include: more general practitioners; making dentistry a specialty of medicine; combining all the clinical material into a compact organization controlled and financed by the
The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis
Authors: H.-M. Koo, M. Gray-Goodrich, G. Kohlhagen, M. J. McWilliams, M. Jeffers, A. Vaigro-Wolff, W. G. Alvord, A. Monks, K. D. Paull, Y. Pommier, G. F. Vande Woude
Journal: JNCI Journal of the National Cancer Institute (1999)

BACKGROUND: Among the inhibitors of the enzyme topoisomerase II (an important target for chemotherapeutic drugs) tested in the National Cancer Institute's In Vitro Antineoplastic Drug Screen, NSC 284682 (3′-hydroxydaunorubicin) and NSC 659687 [ 9-hydroxy-5,6-dimethyl-1-( N- {2(dimethylamino)ethyl}carbamoyl)-6 H -pyrido-(4,3- b )carbazole] were the only compounds that were more cytotoxic to tumor cells harboring an activated ras oncogene than to tumor cells bearing wild-type ras alleles. Expression of the multidrug resistance proteins P-glycoprotein and MRP (multidrug resistance-associated protein) facilitates tumor cell resistance to topoisomerase II inhibitors. We investigated whether tumor cells with activated ras oncogenes showed enhanced sensitivity to other topoisomerase II inhibitors in the absence of the multidrug-resistant phenotype. METHODS: We studied 20 topoisomerase II inhibitors and individual cell lines with or without activated ras oncogenes and with varying degrees of multidrug resistance. RESULTS: In the absence of multidrug resistance, human tumor cell lines with activated ras oncogenes were uniformly more sensitive to most topoisomerase II inhibitors than were cell lines containing wild-type ras alleles. The compounds NSC 284682 and NSC 659687 were especially effective irrespective of the multidrug resistant phenotype. The ras oncogene-mediated sensitization to topoisomerase II inhibitors was far more prominent with the non-DNA-intercalating epipodophyllotoxins than with the DNA-intercalating inhibitors. This difference in sensitization appears to be related to a difference in apoptotic sensitivity, since the level of DNA damage generated by etoposide (an epipodophyllotoxin derivative) in immortalized human kidney epithelial cells expressing an activated ras oncogene was similar to that in the parental cells, but apoptosis was enhanced only in the former cells. CONCLUSIONS: Activated ras oncogenes appear to enhance the sensitivity of human tumor cells to topoisomerase II inhibitors by potentiating an apoptotic response. Epipodophyllotoxin-derived topoisomerase II inhibitors should be more effective than the DNA-intercalating inhibitors against tumor cells with activated ras oncogenes.
ANNUAL CONGRESS ON MEDICAL EDUCATION AND LICENSURE
Authors: Ray Lyman Wilbur
Journal: JAMA (1942)

<h3>COUNCIL ON MEDICAL EDUCATION AND HOSPITALS</h3> February 16—Morning <h3>Medical Care of Civilian Population During War</h3> Dr. Ray Lyman Wilbur, Stanford University, Calif.: War, from the selection of the soldier down to his return to his home after war, compels the very best of medical service. Physicians who join the services are dislocated from their normal environment and they must learn new technics and new mass procedures in order to get properly done the large amount of medical work required. We need think only of the blood bank to realize what differences in procedure there are between now and the Spanish American War or even the first World War. The skills to be learned by the physician are more intricate, more precise and more effective than ever before. The call for good medical care is of primary importance. We must take it for granted as we build up a larger army
Editorial
Authors: M Barthet, B Richard-Molard, R Laugier
Journal: Endoscopy (2010)

Voici donc les résumés concernant l'endoscopie et sélectionnés pour les prochaines Journées Francophones d'Hépato-gastroentérologie et d'oncologie digestive. Le nouveau format de ces JFHOD est un succès que l'on peut juger à l'aune du dynamisme et à de la pertinence des communications en endoscopie digestive. Ces 60 résumés concernent les communications affichées et orales, que ce soit au cours de la session d'endoscopie du jeudi matin, des trois communications des séances plénières ou de la vidéosession. Les posters ne sont pas des communications du »pauvre« mais une forme originale d'affichage permettant une réflexion tranquille et un échange facile avec les auteurs. Ils témoignent de la richesse de la recherche et de l'évaluation en France et aussi dans les pays Francophones, qui participent nombreux aux JFHOD. La thématique est originale et étoffée concernant tous les secteurs: l'imagerie avec la microscopie confocale et les colorations électroniques, l'échoendoscopie thérapeutique, l'endoscopie thérapeutique avec des séries importantes de dissections sous-muqueuses, les nouvelles prothèses ou leurs nouvelles indications, la prise en charge des complications de la chirurgie bariatrique mais aussi l'évaluation du fonctionnement de l'endoscopie digestive en France. Tous ces travaux proviennent de centres hospitaliers universitaires ou généraux mais aussi du monde libéral dont on peut saluer ici la participation active à la recherche et à l'évaluation de l'endoscopie digestive. Alors bonne lecture..et bonne participation aux JFHOD 2010
THE CAUSES OF DEAFNESS
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.
Authors: J. D. Wright, A. I. Neugut, E. T. Wilde, D. Buono, J. Malin, W. Tsai, D. L. Hershman
Journal: Journal of Clinical Oncology (2011)

6020 Background: Often drugs are approved for one indication based on data from randomized clinical trials, however, once approved, these treatments are used in a different manner than tested. We performed a population-based analysis to determine the patterns of use of erythropoiesis-stimulating agent (ESAs). Methods: We used the SEER-Medicare database to identify subjects >65 years old with breast, lung and colon cancer, diagnosed between1995-2005 who had at least 1 ESA and chemotherapy claim. The associations of patient, tumor, and physician-related factors with receipt of ESA were analyzed. Misuse (< 1 week), prolonged use (> 14 weeks) and off-label use (use while off chemotherapy) were examined. Results: Among 21,091 patients analyzed, 5099 (24.2%) received ESA for <1 week (misuse) and 1601 (7.6%) received ESA for >14 weeks (prolonged use). Receipt of ESA while not actively receiving chemotherapy (off-label) occurred in 2876 (13.6%) patients. In a multivariable analysis, ESA misuse was associated with M.D. degree, female physician gender, and earlier year of medical school graduation. Private practice physicians (OR=0.78; 95% CI, 0.72-0.85) and high-volume physicians (OR=0.78; 95% CI, 0.72-0.85) were less likely to use <1 week of ESA. Treatment by a high-volume oncologist (OR=1.35; 95% CI, 1.16-1.58) and by oncologists who graduated from U.S. medical schools (OR=1.35; 95% CI, 1.20-1.51) predicted prolonged duration ESA use, while female oncologists (OR=0.80;95% CI, 0.68-0.94) were less likely to prescribe prolonged ESA. Private practice physicians (OR=1.20; 95% CI 1.03-1.40) and high-volume providers (OR=1.58; 95% CI, 1.34-1.87) were more likely to prescribe > 24 weeks of ESA. Conclusions: We noted widespread variability in the use of erythropoiesis-stimulating agents. Short treatment duration that provides little clinical efficacy, prolonged use, and use while off chemotherapy were common. While patient-related factors influence the patterns of erythropoiesis-stimulating agent use, physician characteristics exerted substantial influence on the way ESAs were administered.
A Dynamic Prognostic Model To Predict Survival in Post-Polycythemia Vera Myelofibrosis.
Authors: Francesco F. Passamonti, Elisa E. Rumi, Marianna M. Caramella, Chiara C. Elena, Luca L. Arcaini, Emanuela E. Boveri, Cecilia C. Del Curto, Daniela D. Pietra, Laura L. Vanelli, Cristiana C. Pascutto, Mario M. Cazzola, Enrica E. Morra, Mario M. Lazzarino
Journal: Blood (2007)
JCAHO Pain Management Standards Are Unveiled
Authors: D. M. Phillips
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
From the alcohol, Drug Abuse, and Mental Health Administration
Authors: F. K. Goodwin
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Acute Gastric Dilatation in Progressive Muscular Dystrophy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal